Similar articles

• Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.

  Vaidya R, Sethi A, Bartol S, Jacobson M, Coe C, Craig JG. Vaidya R, et al. J Spinal Disord Tech. 2008 Dec;21(8):557-62. doi: 10.1097/BSD.0b013e31815ea897. J Spinal Disord Tech. 2008. PMID: 19057248 Clinical Trial.
• Resorptive response of rhBMP2 simulating infection in an anterior lumbar interbody fusion with a femoral ring.

  Hansen SM, Sasso RC. Hansen SM, et al. J Spinal Disord Tech. 2006 Apr;19(2):130-4. doi: 10.1097/01.bsd.0000168512.61351.3a. J Spinal Disord Tech. 2006. PMID: 16760788
• Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? Spine 2009;34:885-9.

  Cimic M, Smoljanovic T, Bojanic I. Cimic M, et al. Spine (Phila Pa 1976). 2010 Feb 1;35(3):361; author reply 361-2. doi: 10.1097/BRS.0b013e3181cb4651. Spine (Phila Pa 1976). 2010. PMID: 20118766 No abstract available.
• Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma.

  Shahlaie K, Kim KD. Shahlaie K, et al. Spine (Phila Pa 1976). 2008 Oct 1;33(21):2361-6. doi: 10.1097/BRS.0b013e318183971d. Spine (Phila Pa 1976). 2008. PMID: 18827703 Review.
• Recombinant human bone morphogenetic protein-2: use in spinal fusion applications.

  Sandhu HS, Khan SN. Sandhu HS, et al. J Bone Joint Surg Am. 2003;85-A Suppl 3:89-95. J Bone Joint Surg Am. 2003. PMID: 12925615 Review. No abstract available.